XML 45 R33.htm IDEA: XBRL DOCUMENT v3.26.1

Financial Instruments and Derivative Instruments (Tables)

3 Months Ended

Mar. 29, 2026

Financial Instruments and Derivative Instruments

Schedule of fair value of financial assets and liabilities

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Fair Value Measurements at March 29, 2026 Using:

​

​

​

​

​

Quoted Prices in Active

​

Significant Other

​

Significant

​

​

​

​

​

Markets for Identical

​

Observable

​

Unobservable

​

​

​

​

​

Assets

​

Inputs

​

Inputs

​

​ ​ ​

Total

​ ​ ​

(Level 1)

​ ​ ​

(Level 2)

​ ​ ​

(Level 3)

​

​

(in millions)

Assets

​

​

​

​

​

​

​

​

​

​

​

​

Plan asset for deferred compensation(1)

​

$

2.9

​

$

2.9

​

$

—

​

$

—

Total assets

​

$

2.9

​

$

2.9

​

$

—

​

$

—

Liabilities

​

​

​

​

​

​

​

​

​

​

​

​

Plan liability for deferred compensation(2)

​

$

2.9

​

$

2.9

​

$

—

​

$

—

Total liabilities

​

$

2.9

​

$

2.9

​

$

—

​

$

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Fair Value Measurements at December 31, 2025 Using:

​

​

​

​

​

Quoted Prices in Active

​

Significant Other

​

Significant

​

​

​

​

​

Markets for Identical

​

Observable

​

Unobservable

​

​ ​ ​

​

​

​

Assets

​

Inputs

​

Inputs

​

​

Total

​ ​ ​

(Level 1)

​ ​ ​

(Level 2)

​ ​ ​

(Level 3)

​

​

(in millions)

Assets

​

​

​

​

​

​

​

​

​

​

​

​

Plan asset for deferred compensation(1)

​

$

3.0

​

$

3.0

​

$

—

​

$

—

Interest rate swap(3)

​

$

0.7

​

$

—

​

$

0.7

​

$

—

Total assets

​

$

3.7

​

$

3.0

​

$

0.7

​

$

—

Liabilities

​

​

​

​

​

​

​

​

​

​

​

​

Plan liability for deferred compensation(2)

​

$

3.0

​

$

3.0

​

$

—

​

$

—

Interest rate swap(4)

​

$

0.3

​

$

—

​

$

0.3

​

$

—

Designated foreign currency hedges(4)

​

$

0.1

​

$

—

​

$

0.1

​

$

—

Total liabilities

​

$

3.4

​

$

3.0

​

$

0.4

​

$

—

(1) Included on the Company’s consolidated balance sheet in other assets (other, net).

​

(2) Included on the Company’s consolidated balance sheet in accrued compensation and benefits.

​

(3) Included on the company’s consolidated balance sheet in prepaid expenses and other current assets.

​

(4) Included on the company’s consolidated balance sheet in accrued expenses and other liabilities.

X

- References

No definition available.

+ Details

Name:	us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration